- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
AbbVie Inc
+ Add to WatchlistABBV:US
43.5400 USD 0.5300 1.23%
Share
As of 20:04:06 ET on 06/18/2013.
More on ABBV
News for AbbVie Inc (ABBV)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Arnold & Porter, Skadden, Cravath, Willkie: Business of Law
- Drugmakers Opened to ‘Pay for Delay’ Suits by High Court
- AbbVie Says It Can Be First With New Hepatitis C Drugs
- Pfizer’s Two New Top Pills Selling Slower Than Expected
- Abbott Doubled Niaspan U.S. Sales Before Trials Cut Use
- Gilead’s Hepatitis C Drug to Get Priority Review by FDA
- Drugs Go From Hit to Dud in Two Years in Hepatitis Race
- Takeda, Biogen, Article One: Intellectual Property
- AbbVie Price Boost of Drug Slammed in Studies Criticized
- MS Patients Choose Death Risk With Potent Drug Treatment
- AbbVie Science Chief to Retire With No Successor in Place
- Half of Hepatitis C Patients Don’t Get Full Testing, CDC Says
- Gilead Rises To Highest Price on Potential Drug Sales
- S&P 500 Stocks Biggest Weekly Changes in Target Price
- Gilead’s Hepatitis C Treatment Clears Virus in Eight Weeks
- AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with Published Jun 17, 2013
- Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Published Jun 15, 2013
- AbbVie Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination with HUMIRA® Published Jun 13, 2013
- Research Study Results Bring Hope for Combating Debilitating Diseases - Research Report on Johnson & Johnson, AbbVie, Lilly, Published Jun 12, 2013
- Avaxia Biologics Closes Series B Financing with Total Proceeds of $11.4 Million Published Jun 07, 2013
- AbbVie to Participate in 34th Annual Goldman Sachs Global Healthcare Conference Published Jun 05, 2013
- Coronado Biosciences Appoints George Avgerinos, Ph.D. as Senior Vice President, Biologics Operations Published Jun 04, 2013
- AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Published Jun 03, 2013
- AbbVie Announces Market Availability of New CREON® (pancrelipase) 36,000 Lipase-unit Capsules for Patients with Exocrine Published May 30, 2013
- AbbVie to Participate in 2013 Jeffries Global Healthcare Conference Published May 28, 2013
- The Zacks Analyst Blog Highlights: Zumiez, Mylan, AbbVie, Santarus and Jazz Pharmaceuticals Published May 23, 2013
- AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Published May 20, 2013
- Marathon Patent Group, Novo Nordisk, Levi: Intellectual Property Updated 3 hours ago
- Almirall CEO on International Expansion, Porfolio
- Almirall CEO Eyes $11.6 Billion COPD Market Smokers Fuel
- Medtronic’s Infuse No Better Than Bone Graft With Risk
- FDA Investigating Lilly’s Zyprexa Injection After Two Die
- Global Power Players: In The Loop (06/14)
- The Top Ten Stocks for Tuesday, June 18
- Glaxo Gets Offer for Heart Drugs With Declining Sales
- Royalty Pharma Drops Judicial Review Request of Elan Bid
- Arnold & Porter, Skadden, Cravath, Willkie: Business of Law
- Drugmakers Opened to ‘Pay for Delay’ Suits by High Court
- The Top Ten Stocks for June 17
- J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
- Investor's Eyes on Bernanke: In The Loop (6/17)
- ViroPharma Shares Rise on Report of Drug Company Interest
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page